Literature DB >> 25992100

Program to diagnose probability of aspiration pneumonia in patients with ischemic stroke.

Gisele Pinto1, Viviane Zétola2, Marcos Lange1, Guilherme Gomes3, Maria Cristina Nunes1, Gisela Hirata4, Hellen Nataly Lagos-Guimarães1.   

Abstract

Introduction Stroke is a major cause of death and disability worldwide, with a strong economic and social impact. Approximately 40% of patients show motor, language, and swallowing disorders after stroke. Objective To evaluate the use of software to infer the probability of pneumonia in patients with ischemic stroke. Methods Prospective and cross-sectional study conducted in a university hospital from March 2010 to August 2012. After confirmation of ischemic stroke by computed axial tomography, a clinical and flexible endoscopic evaluation of swallowing was performed within 72 hours of onset of symptoms. All patients received speech therapy poststroke, and the data were subsequently analyzed by the software. The patients were given medical treatment and speech therapy for 3 months. Results The study examined 52 patients with a mean age of 62.05 ± 13.88 years, with 23 (44.2%) women. Of the 52 patients, only 3 (5.7%) had a probability of pneumonia between 80 and 100% as identified by the software. Of all patients, 32 (61.7%) had pneumonia probability between 0 and 19%, 5 (9.5%) between 20 and 49%, 3 (5.8%) between 50 and 79%, and 12 (23.0%) between 80 and 100%. Conclusion The computer program indicates the probability of patient having aspiration pneumonia after ischemic stroke.

Entities:  

Keywords:  pneumonia; stroke; swallowing disorders

Year:  2014        PMID: 25992100      PMCID: PMC4297022          DOI: 10.1055/s-0034-1374646

Source DB:  PubMed          Journal:  Int Arch Otorhinolaryngol        ISSN: 1809-4864


Introduction

Stroke is a major cause of death and disability worldwide, with a strong economic and social impact. Approximately 40% of patients show motor, language, and swallowing disorders.1 Stroke causes neurogenic oropharyngeal dysphagia (NOD) that, besides limiting food intake, carries a greater risk of malnutrition and tracheal aspiration and triples the incidence of aspiration pneumonia.2 3 4 5 6 This higher risk is due to several factors, such as possibility of silent aspiration (without cough reflex) or microaspiration; motor dysfunction of the pharynx; delayed swallow initiation; presence of pharyngeal residues at epiglottic valleculae, pyriform sinuses, and/or posterior wall of the pharynx; and impairment of the laryngeal closure mechanism. The detection of such risks, in many situations, may require an alternative route for nutrition and hydration.7 NOD occurs in ∼25 to 90% of strokes,8 9 10 similar to the acute phase, when 45% of patients have swallowing disorders, often with tracheal aspiration.11 Tracheal aspiration is defined as the passage of saliva, fluid, or food in the subglottic region below the vocal folds.12 13 It is estimated that 50% of patients with tracheal aspiration will develop aspiration pneumonia.14 Attempting to help physicians better manage dysphagia after stroke, this study used a computer program, Nética Shell (Norsys, Vancouver, Canada),15 which uses Bayesian networks as a tool and shows results in a probabilistic form. Thus, the aim of this research is to evaluate the use of software to infer the probability of pneumonia in patients with ischemic stroke.

Methods

This was a prospective and cross-sectional study of 52 patients after ischemic stroke who were examined from March 2010 to August 2012, with 23 (44.2%) women and 29 (55.8%) men, with mean age of 62.05 ± 13.88 years. Patients were recruited in the emergency room at a university hospital in Curitiba and evaluated by a neurologist of the Neurology Department from the same institution. The diagnosis of ischemic stroke was confirmed clinically and by computed axial tomography. The study included patients of both genders 18 years of age and older who had ischemic stroke according to clinical assessment and imaging study, confirmed by a neurologist, and who underwent clinical and instrumental evaluations of swallowing within the first 72 hours of onset of symptoms of ischemic stroke. The exclusion criteria were patients with a prior history of head and neck surgery, patients with structural abnormalities of oropharynx and larynx, those with a lowered level of consciousness with score less than 10 on the Glasgow Coma Scale,16 those clinically unstable, and patients who refused to sign the informed consent form. The research consisted of two phases performed on the same day using clinical and flexible endoscopic evaluation of swallowing (FEES),17 18 with protocols used by the institution. During clinical swallow evaluation, the patient remained seated in reach of a cup, tablespoon, plastic syringe, and straw. The patient was then offered 5 mL, 10 mL, and free sip of each food consistency following American Dietetic Association standard without interruption between them.19 Then the Functional Oral Intake Scale (FOIS) was administered.18 For FEES,17 the consistencies offered were similar to those used in the preceding phase, but with the addition of aniline blue dye to contrast with pink mucosa. During FEES,17 patients were offered the same sequence of swallows as in the clinical swallow evaluation. In the presence of swallowing difficulty, laryngeal penetration, or tracheal aspiration, consistencies began to be arranged progressively or the examination stopped. The test was discontinued if the patient showed nausea, vomiting, or any clinical instability. The data collected during the test included laryngeal sensitivity, presence of premature spillage, pharyngeal residue (posterior pharyngeal wall, epiglottic valleculae, pyriform sinuses), pharyngeal clearance (after three swallows), and laryngeal penetration or tracheal aspiration (with or no cough reflex). The Severity Scale for Dysphagia—Penetration Aspiration Scale was administered.20 Based on the findings of clinical and instrumental assessments (FEES),17 speech therapy guidance was conducted for the patient, caregiver, and/or family. This research used the safe mode of Bayesian network Nética Shell (Norsys, Vancouver, Canada),15 available on the Internet without charge, and the variables were created based on a previous study.21 The following findings were used as variables: clinical swallow evaluation (oral diet, tube feeding, tracheostomy, level of consciousness, gag reflex, spontaneous swallow, larynx elevation, wet voice, and voluntary cough) and FEES (laryngeal sensitivity, premature spillage, pharyngeal residue and tracheal aspiration). Thereafter, the Bayesian network was used with the findings of phases 1 and 2 (Fig. 1) to investigate the probability of the patient developing aspiration pneumonia. Results were then divided into groups by percentage.
Fig. 1

Bayesian model (Gomes21).

Bayesian model (Gomes21). All patients were followed by the author and the attending physician of the patient during the hospitalization period and fortnightly for 3 months.22 Statistical analysis was performed using descriptive methods, chi-square and difference in proportions tests, with a significance level of 0.05 (5%). The study was approved by the Ethics Committee in Research of HC-UFPR under the number 2098.265/2009-11.

Results

Among the 52 patients, in the clinical swallow evaluation, 30 (57.5%) showed no clinical signs of tracheal aspiration such as coughing, wet voice, and dyspnea,23 and in instrumental evaluation FEES,17 34 (65.4%) showed no tracheal aspiration. There was no significant difference between the clinical swallow evaluation and FEES for the presence of tracheal aspiration (p = 0.4201),17 as shown in Table 1.
Table 1

Comparison of clinical and instrumental swallow evaluations for tracheal aspiration

Tracheal aspirationEvaluations p
ClinicalFEES
Absent30 (57.5%)34 (65.4%)0.4201
Present22 (42.5%)18 (34.6%)
Total52 (100.0%)52 (100.0%)

Abbreviation: FEES, flexible endoscopic evaluation of swallowing.

Abbreviation: FEES, flexible endoscopic evaluation of swallowing. Of the 18 patients (34.6%) who had aspirated food consistencies during the examination, 14 patients (66.6%) had tracheal aspiration of pudding consistency, 12 (57.1%) of honey consistency, 13 (61.9%) of nectar consistency, and 17 (80.9%) of liquid consistency. Regarding FOIS,24 13 (25.0%) of the patients were at level 1 (nothing by mouth), 1 (1.7%) patient was at level 2 (tube-dependent with minimal attempts of food or liquid), 1 (1.7%) patient was at level 3 (tube-dependent with consistent oral intake of food or liquid), 2 (4.0%) patients were at level 4 (total oral diet of a single consistency), 5 (9.5%) patients were at level 5 (total oral diet with multiple consistencies, but requiring special preparation or compensations), 2 (4.0%) patients were at level 6 (total oral diet with multiple consistencies without special preparation, but with specific food limitations), and 28 (53.9%) patients were at level 7 (total oral diet with no restrictions), as shown in Table 2.
Table 2

Distribution of patients in FOIS scale

FOISNumber of patients
113 (25.0%)
21(1.7%)
31 (1.7%)
42 (4.0%)
55 (9.5%)
62 (4.0%)
728 (53.9%)
Total52 (100.0%)

Abbreviation: FOIS, Functional Oral Intake Scale.

Abbreviation: FOIS, Functional Oral Intake Scale. The Rosenbeck Scale20 showed no significant relationship between the scale and the presence or absence of pneumonia (p = 0.2293; Table 3).
Table 3

Relation between Rosenbek scale and aspiration pneumonia

Aspiration pneumoniaRosenbek scale p
12345678
Present001000110.2293
Absent3011100412
To allow the difference in proportions test, groups were considered in two categories: 0 to 49% and 50 to 100%. Thus, difference in proportions test, with level of significance of 0.05, resulted in p < 0.001, that is, the proportion of patients in category 0 to 49% was significantly higher than in the category of 50 to 100% (Table 4).
Table 4

Number of patients by percentage groups of probability of pneumonia aspiration

Software p
Groups by % probability of pneumoniaNumber of patients
0–19%32 (61.7%)
20–49%5 (9.5%)
50–79%3 (5.7%)<0.001
80–100%12 (23.1%)
Total52 (100.0%)
Table 5 demonstrates the presence and absence of aspiration pneumonia within the group of patients with odds > 80% of having aspiration pneumonia and software variables. In the 3-month follow-up, only three patients had aspiration pneumonia; Table 6 shows the outcome shown since the stroke.
Table 5

Relation between aspiration pneumonia and patients with probability >80% for pneumonia

PneumoniaProbability 80–100%
Present3 (25.0%)
Absent9 (75.0%)
Total12 (100.0%)
Table 6

Distribution of the outcome of three patients stricken by pneumonia

n GenderAge (y)FOISRosenbek scaleFEESSoftware %Upshot
1F8673Laryngeal penetration85.20Decreased consciousness, pneumonia and death
2M8347Tracheal aspiration98.41Sepsis, pneumonia and death
3M7418Tracheal aspiration99.50Decreased consciousness, pneumonia, and death

Abbreviations: FEES, flexible endoscopic evaluation of swallowing; FOIS, Functional Oral Intake Scale.

Abbreviations: FEES, flexible endoscopic evaluation of swallowing; FOIS, Functional Oral Intake Scale.

Discussion

The present study implemented software to assess the probability of aspiration pneumonia in patients with acute ischemic stroke. It is not noted in the literature that any software can predict aspiration pneumonia in this population. Studies have shown that NOD with risk of tracheal aspiration is present in up to half of patients after acute ischemic stroke.9 10 25 This finding is similar to the one obtained in the present study, in which 22 (42.5%) had oropharyngeal dysphagia in clinical swallow evaluation and 18 (34.6%) in the instrumental evaluation. The difference in values between assessments is probably due to the fact that in the clinical swallow evaluation, some patients showed signs of tracheal aspiration such as coughing, wet voice, and dyspnea,23 which was not confirmed in the instrumental evaluation. Importantly, often the clinical swallow evaluation is used to determine the next procedure with the patient in the acute phase of ischemic stroke—that is, if oral diet is or not safe for the patient.18 26 Some authors recommend a clinical swallow evaluation initially followed by an instrumental evaluation as a complementary test.26 In this study, all patients also submitted to the instrumental assessment, and the prevalence of tracheal aspiration was tested in liquid consistency. A recent study indicated that food in a liquid consistency is more likely to induce laryngeal penetration and that increased viscosity of food reduces the possibility of tracheal aspiration.27 28 After the instrumental evaluation, patients were classified by the Severity Scale20; nothing was found in the literature correlating the scale with aspiration pneumonia. Nevertheless, in our study the three patients with aspiration pneumonia scored 3, 7, and 8 in the Rosenbeck Scale,20 resulting in death, agreeing with the authors that patients with tracheal aspiration can have aspiration pneumonia leading to morbidity and mortality of patients.9 29 Our goal was to introduce clinical and instrumental swallow evaluation data in the software using the same variables present in a previous study.21 After analysis, the probability of each patient to develop aspiration pneumonia was assessed in percentages. It is noteworthy that the small number of cases of aspiration pneumonia in this study do not invalidate the variables used in the software, as they are consistent with aspiration pneumonia. It is also important to mention that all patients, including the caregiver and the family, received speech therapy guidelines regarding posture, proper use of dental prosthesis, speed during feeding, amount of food to be chewed, preparation of bolus, food consistency, and head posture to prevent tracheal aspiration and consequently the nondevelopment of pneumonia. These positive results in our study are similar to other studies that show a reduction in clinical complications with preventive and therapeutic measures in acute stroke patients.26 Teamwork of a multidisciplinary unit with a speech therapist ensures patient safety during feeding and avoids the risks of tracheal aspiration.

Conclusion

The software is indicative of the probability of the patient having aspiration pneumonia, but the sample was not sufficient. A larger sample size is required, along with continuity of this study.
  17 in total

Review 1.  Silent aspiration: what do we know?

Authors:  Deborah Ramsey; David Smithard; Lalit Kalra
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

2.  [Relation between clinical evaluation of deglutition and the computed tomography in acute ischemic stroke patients].

Authors:  Anna Flávia Ferraz Barros; Soraia Ramos Cabette Fábio; Ana Maria Furkim
Journal:  Arq Neuropsiquiatr       Date:  2006-12       Impact factor: 1.420

3.  A penetration-aspiration scale.

Authors:  J C Rosenbek; J A Robbins; E B Roecker; J L Coyle; J L Wood
Journal:  Dysphagia       Date:  1996       Impact factor: 3.438

Review 4.  [Management of dysphagic patients with acute stroke].

Authors:  M Prosiegel; A Riecker; M Weinert; R Dziewas; B Lindner-Pfleghar; S Stanschus; T Warnecke
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

Review 5.  Screening for dysphagia and aspiration in acute stroke: a systematic review.

Authors:  L Perry; C P Love
Journal:  Dysphagia       Date:  2001       Impact factor: 3.438

6.  Risk factors for swallowing dysfunction in stroke patients.

Authors:  Anna Flávia Ferraz Barros Baroni; Soraia Ramos Cabette Fábio; Roberto Oliveira Dantas
Journal:  Arq Gastroenterol       Date:  2012 Apr-Jun

7.  Mortality and cost of pneumonia after stroke for different risk groups.

Authors:  Richard D Wilson
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-06-17       Impact factor: 2.136

8.  [Incidence of oropharyngeal dysphagia associated with stroke in a regional hospital in São Paulo State - Brazil].

Authors:  Arthur Oscar Schelp; Paula Cristina Cola; Ana Rita Gatto; Roberta Gonçalves da Silva; Lídia Raquel de Carvalho
Journal:  Arq Neuropsiquiatr       Date:  2004-07-20       Impact factor: 1.420

Review 9.  Oropharyngeal dysphagia and nutritional management.

Authors:  Jeri A Logemann
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-09       Impact factor: 4.294

10.  Correlation between brain injury and dysphagia in adult patients with stroke.

Authors:  Maria Cristina de Alencar Nunes; Ari Leon Jurkiewicz; Rosane Sampaio Santos; Ana Maria Furkim; Giselle Massi; Gisele Sant Ana Pinto; Marcos Christiano Lange
Journal:  Int Arch Otorhinolaryngol       Date:  2012-07
View more
  5 in total

1.  Dysphagia and Associated Pneumonia in Stroke Patients from Brazil: A Systematic Review.

Authors:  Aline Cristina Pacheco-Castilho; Gabriela de Martini Vanin; Roberto Oliveira Dantas; Octávio Marques Pontes-Neto; Rosemary Martino
Journal:  Dysphagia       Date:  2019-05-20       Impact factor: 3.438

2.  Monocyte-to-lymphocyte ratio as a predictor of stroke-associated pneumonia: A retrospective study-based investigation.

Authors:  Feng Cao; Yu Wan; Chunyan Lei; LianMei Zhong; HongTao Lei; Haimei Sun; Xing Zhong; YaDan Xiao
Journal:  Brain Behav       Date:  2021-05-04       Impact factor: 2.708

3.  Predictors of intensive care unit admission and mortality in patients with ischemic stroke: investigating the effects of a pulmonary rehabilitation program.

Authors:  Belma Doğan Güngen; Abdulkadir Tunç; Yeşim Güzey Aras; Aslı Aksoy Gündoğdu; Adil Can Güngen; Serdar Bal
Journal:  BMC Neurol       Date:  2017-07-11       Impact factor: 2.474

4.  Percutaneous Endoscopic Gastrostomy versus Nasogastric Tube Feeding: Oropharyngeal Dysphagia Increases Risk for Pneumonia Requiring Hospital Admission.

Authors:  Wei-Kuo Chang; Hsin-Hung Huang; Hsuan-Hwai Lin; Chen-Liang Tsai
Journal:  Nutrients       Date:  2019-12-05       Impact factor: 5.717

5.  Mean platelet volume to platelet count ratio as a laboratory indicator of mortality in pneumonia following ischemic stroke.

Authors:  Rania S Nageeb; Mohammed M N Abozaid; Ghada S Nageeb; Alaa A Omran
Journal:  Egypt J Neurol Psychiatr Neurosurg       Date:  2018-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.